Toggle Navigation
Each
Pod
Each
Pod
Podcasts
Episodes
Genres
Login
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Tirzepatide (Zepbound) Approved for Chronic Weight Management
Tirzepatide (Zepbound) Approved for Chronic Weight Management
Author
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Published
Wed 08 Nov 2023
Episode Link
https://audioboom.com/posts/8401848
In this episode, hosts discuss the FDA's approval of tirzeptiade (Zepbound) as an adjunct to lifestyle modification for the chronic weight management in people with overweight or obesity.
Share to: